MedMira Inc.
MMIRF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -14.3% | -14.3% | 11.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62% | 72.8% | 66.1% | 85.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -893.8% | -1,099% | -1,267.7% | -1,585.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,482.2% | -1,663.5% | -1,739% | -2,107.1% |
| EPS Diluted | -0.001 | -0.001 | -0.002 | -0.002 |
| % Growth | -10% | 33.3% | 21.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |